Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade

Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update

(2019) Nelesh P. Govender et al.   SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE

Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment

(2018) Miwha Chang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa

(2018) Síle F. Molloy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update

(2017) The Southern African HIV Clinicians Society   SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE

In vitro antifungal susceptibility profiles of Cryptococcus species isolated from HIV-associated cryptococcal meningitis patients in Zimbabwe

(2016) Tinashe K. Nyazika et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Emergence of azole-resistantCandida parapsilosiscausing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa

(2016) Nelesh P. Govender et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa

(2016) Susan Meiring et al.   PLoS Neglected Tropical Diseases

Integrated therapy for HIV and cryptococcosis

(2016) Sirawat Srichatrapimuk et al.   AIDS Research and Therapy

Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda

(2015) Kyle D. Smith et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study

(2015) Yi-Chun Chen et al.   BMC INFECTIOUS DISEASES

Multilocus Sequence Typing of Serially Collected Isolates of Cryptococcus from HIV-Infected Patients in South Africa

(2014) M. Van Wyk et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

(2012) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates Obtained through Population-Based Surveillance in South Africa in 2002-2003 and 2007-2008

(2011) Nelesh P. Govender et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid Identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by Use of Rapid Biochemical Tests, Differential Media, and DNA Sequencing

(2011) Lisa McTaggart et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Oropharyngeal candidiasis in the era of antiretroviral therapy

(2010) George R. Thompson et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS

Heteroresistance to Fluconazole in Cryptococcus neoformans Is Intrinsic and Associated with Virulence

(2009) E. Sionov et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

(2009) Paul E Verweij et al.   LANCET INFECTIOUS DISEASES